1,308 results on '"McCloskey, E"'
Search Results
2. A new FRAX model for Brazil
3. Dynapenic Abdominal Obesity as a Risk Factor for Falls
4. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan
5. Population screening for fracture risk in postmenopausal women — a logical step in reducing the osteoporotic fracture burden?
6. Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
7. Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
8. One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD
9. FRAX-based intervention thresholds for Pakistan
10. Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data
11. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines: A report for the National Osteoporosis Guideline Group (NOGG)
12. Impact of population-based or targeted BMD interventions on fracture incidence
13. The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture
14. Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study
15. Short time horizons for fracture prediction tools: time for a rethink
16. Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review
17. A meta-analysis of previous falls and subsequent fracture risk in cohort studies
18. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
19. Individuals with high bone mass have increased progression of radiographic and clinical features of knee osteoarthritis
20. Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women
21. The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
22. Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
23. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
24. Use of an electronic medical record dashboard to identify gaps in osteoporosis care
25. A surrogate FRAX model for Pakistan
26. A country-specific FRAX model for Botswana
27. Epidemiology of hip fracture in Botswana
28. Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study
29. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
30. FRAX-based intervention and assessment thresholds for osteoporosis in Iran
31. Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts
32. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis
33. The effects of changing sheep breeds on uplands vegetation
34. Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
35. Comparison of HR-pQCT- and microCT-based finite element models for the estimation of the mechanical properties of the calcaneus trabecular bone
36. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
37. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
38. A surrogate FRAX model for the Kyrgyz Republic
39. Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan
40. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
41. Appendicular lean mass and fracture risk assessment: implications for FRAX® and sarcopenia
42. Characteristics of recurrent fractures
43. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
44. Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study
45. Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
46. Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry
47. Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers
48. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry
49. UK clinical guideline for the prevention and treatment of osteoporosis
50. An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.